Cover Image
市場調查報告書

BHR Pharma, LLC - 產品平台分析

BHR Pharma, LLC - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 276026
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
BHR Pharma, LLC - 產品平台分析 BHR Pharma, LLC - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 24 Pages
簡介

BHR Pharma, LLC. 是配合各種醫療需求,製造並提供非口服藥物遞送系統的製藥公司。代表性產品有黃體激素注射,經皮雌激素·凝膠,Afimoxifene。該公司的經皮遞送系統、強化水性酒精凝膠是對於開發非口服製藥新產品而言非常有效的技術。

本報告提供USV Limited的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

BHR Pharma, LLC的基本資料

BHR Pharma, LLC概要

  • 主要資訊
  • 企業資料

BHR Pharma, LLC:R&D概要

  • 主要的治療範圍

BHR Pharma, LLC:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

BHR Pharma, LLC:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

BHR Pharma, LLC:開發階段不明的開發中產品

  • 開發階段不明的產品/聯合治療模式

BHR Pharma, LLC:藥物簡介

  • progesterone
  • afimoxifene
  • BHR-310
  • estradiol

BHR Pharma, LLC:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

BHR Pharma, LLC:最近的開發平台趨勢

BHR Pharma, LLC:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06937CDB

Summary

Global Markets Direct's, 'BHR Pharma, LLC - Product Pipeline Review - 2015', provides an overview of the BHR Pharma, LLC's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of BHR Pharma, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of BHR Pharma, LLC including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of BHR Pharma, LLC's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the BHR Pharma, LLC's pipeline products

Reasons to buy

  • Evaluate BHR Pharma, LLC's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of BHR Pharma, LLC in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the BHR Pharma, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of BHR Pharma, LLC and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of BHR Pharma, LLC
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of BHR Pharma, LLC and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • BHR Pharma, LLC Snapshot
    • BHR Pharma, LLC Overview
    • Key Information
    • Key Facts
  • BHR Pharma, LLC - Research and Development Overview
    • Key Therapeutic Areas
  • BHR Pharma, LLC - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • BHR Pharma, LLC - Pipeline Products Glance
    • BHR Pharma, LLC - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • BHR Pharma, LLC - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • BHR Pharma, LLC - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • BHR Pharma, LLC - Drug Profiles
    • progesterone
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • afimoxifene
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • estradiol
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BHR-310
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • BHR Pharma, LLC - Pipeline Analysis
    • BHR Pharma, LLC - Pipeline Products by Target
    • BHR Pharma, LLC - Pipeline Products by Route of Administration
    • BHR Pharma, LLC - Pipeline Products by Molecule Type
    • BHR Pharma, LLC - Pipeline Products by Mechanism of Action
  • BHR Pharma, LLC - Recent Pipeline Updates
  • BHR Pharma, LLC - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • BHR Pharma, LLC, Key Information
  • BHR Pharma, LLC, Key Facts
  • BHR Pharma, LLC - Pipeline by Indication, 2015
  • BHR Pharma, LLC - Pipeline by Stage of Development, 2015
  • BHR Pharma, LLC - Monotherapy Products in Pipeline, 2015
  • BHR Pharma, LLC - Phase III, 2015
  • BHR Pharma, LLC - Phase II, 2015
  • BHR Pharma, LLC - Preclinical, 2015
  • BHR Pharma, LLC - Pipeline by Target, 2015
  • BHR Pharma, LLC - Pipeline by Route of Administration, 2015
  • BHR Pharma, LLC - Pipeline by Molecule Type, 2015
  • BHR Pharma, LLC - Pipeline Products by Mechanism of Action, 2015
  • BHR Pharma, LLC - Recent Pipeline Updates, 2015

List of Figures

  • BHR Pharma, LLC - Pipeline by Top 10 Indication, 2015
  • BHR Pharma, LLC - Pipeline by Stage of Development, 2015
  • BHR Pharma, LLC - Monotherapy Products in Pipeline, 2015
  • BHR Pharma, LLC - Pipeline by Top 10 Target, 2015
  • BHR Pharma, LLC - Pipeline by Top 10 Route of Administration, 2015
  • BHR Pharma, LLC - Pipeline by Top 10 Molecule Type, 2015
  • BHR Pharma, LLC - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top